Search

everythinglearnresearchcommunity

for

Search:↓

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Transvaginal hydrolaparoscopy is effective for increasing ovulation and pregnancy rates in women with PCOS who didn't respond to clomiphene.

Young women with PCOS and no other heart risk factors have normal heart function.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

Oregano extract helps fix testis and sperm damage caused by finasteride.

Nonobese, normotensive Indian women with PCOS may have a higher risk of heart problems linked to inflammation and insulin resistance.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Finasteride may cause male infertility, stopping it can help.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

Certain gene variations are not a major cause of male infertility in Nigerian men.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

COVID-19 may harm male fertility and damage the reproductive system.

Different diagnostic criteria greatly affect PCOS diagnosis rates in teenagers.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.